6 medicamentos comunes que pueden reducir el riesgo de demencianews2026-04-19T09:04:11+00:00April 19th, 2026|The New York Times|
6 Common Medications That May Decrease Dementia Risknews2026-04-17T09:00:10+00:00April 17th, 2026|The New York Times|
The New Alzheimer’s Blood Tests: What to Knownews2026-03-19T09:00:17+00:00March 19th, 2026|The New York Times|
How Drinking Alcohol Affects You in Older Agenews2025-07-03T09:00:47+00:00July 3rd, 2025|The New York Times|
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’snews2024-07-02T18:58:44+00:00July 2nd, 2024|The New York Times|
Hace casi un año se aprobó un fármaco para frenar el alzhéimer. ¿Ha funcionado?news2024-06-17T21:59:44+00:00June 17th, 2024|The New York Times|
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lillynews2024-06-10T21:05:19+00:00June 10th, 2024|The New York Times|
Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and Benefitsnews2024-06-10T09:00:35+00:00June 10th, 2024|The New York Times|
¿Qué es polifarmacia y cómo tratarla?news2024-04-23T07:00:40+00:00April 23rd, 2024|The New York Times|
Taking Multiple Medications? You May Need to Scale Back.news2024-04-22T18:53:41+00:00April 22nd, 2024|The New York Times|
